This document discusses using circulating tumor cells (CTCs) to diagnose cancer. It notes that current cancer detection technologies like CT, MRI, cell search, and flow cytometry have limitations like high costs, lengthy turnaround times, and invasive sampling procedures. The document proposes using CTCs, which are cancer cells that break off from tumors and circulate in the bloodstream, as a less invasive method of cancer diagnosis and detection. It suggests CTC analysis could provide advantages over existing technologies by offering faster results, lower costs, and a non-invasive blood test alternative to tissue biopsies.